The closing price of Checkpoint Therapeutics Inc (NASDAQ: CKPT) was $1.69 for the day, down -1.74% from the previous closing price of $1.72. On the day, 506942 shares were traded.
Ratios:
Our analysis of CKPT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.29.
On June 09, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $18.
On January 20, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $16.Cantor Fitzgerald initiated its Overweight rating on January 20, 2021, with a $16 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 28 ’24 when Oliviero James F III sold 5,894 shares for $2.06 per share. The transaction valued at 12,142 led to the insider holds 350,836 shares of the business.
GRAY WILLIAM GARRETT sold 2,035 shares of CKPT for $4,212 on Feb 28 ’24. The Chief Financial Officer now owns 145,224 shares after completing the transaction at $2.07 per share. On Feb 01 ’24, another insider, Oliviero James F III, who serves as the CEO, President and Director of the company, sold 11,900 shares for $2.01 each. As a result, the insider received 23,919 and left with 369,680 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 603.16.
Stock Price History:
Over the past 52 weeks, CKPT has reached a high of $3.62, while it has fallen to a 52-week low of $1.30.
Shares Statistics:
A total of 35.69M shares are outstanding, with a floating share count of 30.61M. Insiders hold about 14.22% of the company’s shares, while institutions hold 13.58% stake in the company.
